Voyager Therapeutics

126 articles with Voyager Therapeutics

• Voyager Therapeutics Reports First Quarter 2017 Financial Results And Corporate Highlights

  5/10/2017

• Voyager Therapeutics Announces Additional Results From Phase Ib Trial Of VY-AADC01 For Advanced Parkinson’s Disease

  4/25/2017

• Voyager Therapeutics To Host Fourth Quarter And Full Year 2016 Financial Results Conference Call

  3/8/2017

• Voyager Therapeutics Appoints Jane Pritchett Henderson As Chief Financial Officer

  1/3/2017

• Voyager Therapeutics Soars as Parkinson’s Drug Shines in Early-Stage Trial

  12/8/2016

• MRI Interventions’ Clearpoint Neuro Navigation System Utilized In Voyager Therapeutics’ VY-AADC01 Phase Ib Trial; Positive Interim Results Reported

  12/8/2016

• DNA Brain Injection Could Help Control Parkinson's Symptoms, Voyager Therapeutics Reveals

  8/23/2016

• MRI' Clearpoint Neuro Navigation Technology Highlighted In Voyager Therapeutics Interim Parkinson’s Disease Gene Therapy Study Results

  6/24/2016

• Voyager Therapeutics Announces Interim Phase 1b Surgical Results For VY-AADC01 In Advanced Parkinson’s Disease

  6/22/2016

• Voyager Therapeutics Provides First Quarter 2016 Investor Update

  5/12/2016

• Voyager Therapeutics Promotes Jeff Goater To Chief Financial Officer

  2/3/2016

• Voyager Therapeutics Announces Closing Of Initial Public Offering, Including Full Exercise Of Option To Purchase Additional Shares

  11/17/2015

• Voyager Therapeutics Reels in $70 Million in IPO

  11/11/2015

• Voyager Therapeutics Plans IPO of Up to $86.3 Million

  10/12/2015

• Voyager Therapeutics Appoints Neuroscience Expert Steven Hyman, M.D., To Board Of Directors

  9/17/2015

• Voyager Therapeutics Appoints Michael Higgins To Board Of Directors

  7/22/2015

• Voyager Therapeutics Appoints Perry A. Karsen To Board Of Directors

  7/1/2015

• Voyager Therapeutics To Present At The American Society Of Gene & Cell Therapy 18th Annual Meeting

  5/5/2015

• Voyager Therapeutics Promotes Jeff Goater To Senior Vice President, Finance And Business Development

  4/28/2015

• Voyager Therapeutics Snags $60 Million With "Crossover" Investors as Analysts Predict an IPO

  4/13/2015